Friday, November 6, 2026
BTC $75,847 ▼ 4.80%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
BTC$75,847down−4.80%ETH$2,236down−6.31%SOL$90.26down−5.28%XRP$1.19down−9.20%LINK$10.87down−4.76%ADA$0.186down−3.97%S&P 5007,354down−4.36%Nasdaq24,315down−5.52%Dow51,523down−3.44%RUT2,730down−4.45%TNX4.87%up+0.76%TYX5.28%up+0.63%FVX4.65%up+0.91%IRX4.00%up+0.28%VIX27.02down−4.12%GOLD$4,055.70down−1.41%SILVER$51.96down−0.80%OIL$91.16up+0.71%DXY102.22up+0.66%NVDA$181.60down−9.26%AAPL$344.17down−1.53%TSLA$343.69down−10.77%META$605.08down−3.96%MSFT$535.93down−3.58%AMZN$260.21down−2.19%GOOGL$282.57down−2.20%Fear & Greed28 — FearBTC$75,847down−4.80%ETH$2,236down−6.31%SOL$90.26down−5.28%XRP$1.19down−9.20%LINK$10.87down−4.76%ADA$0.186down−3.97%S&P 5007,354down−4.36%Nasdaq24,315down−5.52%Dow51,523down−3.44%RUT2,730down−4.45%TNX4.87%up+0.76%TYX5.28%up+0.63%FVX4.65%up+0.91%IRX4.00%up+0.28%VIX27.02down−4.12%GOLD$4,055.70down−1.41%SILVER$51.96down−0.80%OIL$91.16up+0.71%DXY102.22up+0.66%NVDA$181.60down−9.26%AAPL$344.17down−1.53%TSLA$343.69down−10.77%META$605.08down−3.96%MSFT$535.93down−3.58%AMZN$260.21down−2.19%GOOGL$282.57down−2.20%Fear & Greed28 — Fear
Tag

liquid biopsy

1 article

Jefferies Initiates Freenome With Buy, Sees 47% Upside in Cancer Screening
U.S. Equities80d ago
Jefferies Initiates Freenome With Buy, Sees 47% Upside in Cancer Screening
Jefferies set a $17 price target on Freenome (FRNM), trading at $11.56, citing the company's cancer screening potential as the core catalyst